Literature DB >> 26699363

Guest editorial: Human mesenchymal stromal/stem cell (MSC).

Yasuo Miura1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26699363     DOI： 10.1007/s12185-015-1931-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  12 in total

1.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

2.  Prospective isolation of resident adult human mesenchymal stem cell population from multiple organs.

Authors:  Yo Mabuchi; Yumi Matsuzaki
Journal:  Int J Hematol       Date:  2015-12-16       Impact factor: 2.490

Review 3.  Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications.

Authors:  Nayoun Kim; Seok-Goo Cho
Journal:  Int J Hematol       Date:  2015-12-11       Impact factor: 2.490

Review 4.  Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns.

Authors:  Koichi Miyamura
Journal:  Int J Hematol       Date:  2016-01-12       Impact factor: 2.490

Review 5.  Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology.

Authors:  Yasuo Miura
Journal:  Int J Hematol       Date:  2015-12-21       Impact factor: 2.490

6.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

7.  The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche.

Authors:  Yoshiki Omatsu; Tatsuki Sugiyama; Hiroshi Kohara; Gen Kondoh; Nobutaka Fujii; Kenji Kohno; Takashi Nagasawa
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

8.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

9.  Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia.

Authors:  Marc H G P Raaijmakers; Siddhartha Mukherjee; Shangqin Guo; Siyi Zhang; Tatsuya Kobayashi; Jesse A Schoonmaker; Benjamin L Ebert; Fatima Al-Shahrour; Robert P Hasserjian; Edward O Scadden; Zinmar Aung; Marc Matza; Matthias Merkenschlager; Charles Lin; Johanna M Rommens; David T Scadden
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494
View more
  1 in total

1.  High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling.

Authors:  Dayong Zhang; Huifei Lu; Zhongxing Chen; Yayan Wang; Jiuzhou Lin; Shan Xu; Chong Zhang; Baoming Wang; Zhanggen Yuan; Xiao Feng; Xuefan Jiang; Jianping Pan
Journal:  Mol Med Rep       Date:  2017-06-21       Impact factor: 2.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.